Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
- Lancet Diabetes Endocrinol., Volume 10, Issue 3, March 2022, Pages 193-206 | https://doi.org/10.1016/S2213-8587(22)00008-0